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WORLDWIDE, THE ANNUALnumber of hip frac-tures is expected to in-crease from 1.66 mil-
lion in 1990 to 6.26 million in 2050.1
This is caused by not only the increas-
ing number of elderly persons, but also
an increase in the age-adjusted inci-
dence.2-6 The risk for hip fracture is
higher among elderly persons who are
institutionalized than those living in-
dependently.7 The consequences of hip
fractures can be severe. During the year
following a hip fracture, the mortality
rate is about 17% to 33%; after 1 year,
25% to 33% of patients are severely dis-
abled or cannot walk at all.8-11 A prom-
ising intervention in the prevention of
hip fractures is the hip protector.12
When a person falls on the hip, the hip
protector is designed to absorb and/or
shunt away the impact toward the soft
tissues to keep the force on the tro-
chanter below the fracture threshold.
To date, 10 randomized controlled
trials examining the effect of external hip
protectors on the incidence of hip frac-
tures have beenpublished to our knowl-
edge.13-22 In 5 studies, hip protectors led
to a statistically significant reduction in
the incidence of hip fractures13,14,16,17,19;
2 studies were borderline statistically
significant15,22; and 3 studies were not
statistically significant.18,20,21 In 2
studies, only the fracture rate per fall
was calculated.16,21 However, 4 of 10
studies were rather small (200
participants)14,16,18,19; and 5 studies did
not use individual randomization to as-
sign persons to the hip protector or con-
trol group.13,15,17,19,22 In 2 relatively large
studies that used individual randomiza-
tion, hip protectorswere not effective in
preventing hip fractures.20,21
Author Affiliations: Institute for Research in Extra-
mural Medicine (Drs Twisk, Bouter, and Lips and Ms
van Schoor), Departments of Sociology and Social Ger-
ontology (Dr Smit), Clinical Epidemiology and Biosta-
tistics (Dr Twisk), and Endocrinology (Dr Lips), Vrije
Universiteit Medical Center, Amsterdam, the Neth-
erlands.
Financial Disclosures: Dr Lips has received research
grants from Eli Lilly, Merck and Co, and Organon. He
is on an advisory board at Merck and Co.
Corresponding Author and Reprints: Paul Lips, MD,
PhD, Department of Endocrinology, Vrije Universit-
eit Medical Center, PO Box 7057, 1007 MB Amster-
dam, the Netherlands (e-mail: p.lips@vumc.nl).
Context Several randomized controlled trials have been performed to examine the
effectiveness of external hip protectors in reducing the incidence of hip fractures, but
the results are controversial.
Objective To examine the effectiveness of hip protectors in reducing the incidence
of hip fractures in an elderly high-risk population.
Design, Setting, and Participants Randomized controlled trial of elderly persons
aged 70 years or older, who have low bone density, and are at high risk for falls. Par-
ticipants lived in apartment houses for the elderly, homes for the elderly, and nursing
homes in Amsterdam and surrounding areas in the Netherlands. They were enrolled
in the study between March 1999 and March 2001; the mean follow-up was 69.6
weeks. Of the 830 persons who were screened, 561 persons were enrolled.
Intervention External hip protector. Both groups received written information on
bone health and risk factors for falls.
Main Outcome Measure Time to first hip fracture. Survival analysis was used to
include all participants for the time they participated.
Results In the intervention group, 18 hip fractures occurred vs 20 in the control group.
Four hip fractures in the intervention group occurred while an individual was wearing
a hip protector. At least 4 hip fractures in the intervention group occurred late at night
or early in the morning. Both in univariate analysis (log-rank P=.86) and in multivar-
iate analysis (hazard ratio [HR], 1.05; 95% confidence interval [CI], 0.55-2.03), no
statistically significant difference between the intervention group and control group
was found with regard to time to first hip fracture. In addition, the per protocol analy-
sis in compliant participants did not show a statistically significant difference between
the groups (HR, 0.77; 95% CI, 0.25-2.38).
Conclusion The hip protector studied was not effective in preventing hip fractures.
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The AmsterdamHip Protector Study
was designed to examine the effective-
ness of external hip protectors in the
prevention of hip fractures. This large
randomized controlled trial used indi-
vidual randomization to assign per-
sons to the intervention or control
group to address some of the limita-
tions of previous studies.
METHODS
TheAmsterdamHipProtector Studywas
designedas a randomizedcontrolled trial
in which individuals were randomized
to the hip protector group or to the con-
trol group in a 1:1 ratio. The study en-
rolled residents of apartment houses for
the elderly, homes for the elderly, and
nursing homes in Amsterdam and sur-
rounding areas in the Netherlands.
Apartmenthouses for the elderly, homes
for the elderly, and nursing homes are
characterized by increasing depen-
dence andcare. Special adaptations, such
as grip bars and adequate illumination,
are present in all 3 types of housing. In
apartmenthouses,nonursingstaff ispres-
ent, but home care can be provided.
All persons included in the study had
to have a high risk for hip fractures. The
follow-up duration was at least 1 year
for all participants (those who started
first continued in the study until the last
participants had been followed up for
1 year). The ethical review board at the
Vrije Universiteit Medical Center ap-
proved the study and all respondents
(or their proxies in case of cognitive im-
pairment) gave informed consent.
The screeningconsistedof aboneden-
sity measurement and a fall risk assess-
ment. Bone density was assessed by an
ultrasoundmeasurement (broadbandul-
trasound attenuation [BUA]) of the cal-
caneus.23 In addition, the risk factors of
(1) 1 or more falls during the previous
half year; (2)dizzinesswhile standingup
from a chair in the last 2weeks; (3) hav-
ing had a stroke in the past with sus-
tained neurological impairment (ie,
hemiparesis); (4) urinary inconti-
nence; (5) low physical activity; (6) im-
paired mobility; and (7) cognitive im-
pairment were assessed.24,25 The first 5
risk factors were assessed by interview-
ing theparticipant.When itwasnot pos-
sible to interview the participant (eg, in
case of cognitive impairment), a nurse
of theward inwhich the participantwas
living was interviewed. Physical activ-
ity was assessed by asking the partici-
pant if he/she did some walking, cy-
cling, or heavy household tasks during
the last 2 weeks. Low physical activity
was defined as not performing these ac-
tivities. Mobility was assessed by the
walking observation scale,which ranges
from 1 (he/she cannot walk) to 5 (he/
she is able towalk independently for 100
mon any surface including stairs).26 Im-
pairedmobilitywas defined as a score of
3 or less. Cognitive impairment was de-
fined as a score of 23 or less on theMini-
Mental State Examination (range,
0-30).27 Individuals living on a psycho-
geriatric ward were assumed to have a
cognitive impairment, but theheadof the
department was also consulted for con-
firmation.
Persons were included when they
were aged 70 years or older, had low
bone density, and/or a high risk for fall-
ing as determined by (1) BUA of 40 dB/
MHzor less; or (2) BUAbetween 40 and
60 dB/MHz and at least 2 risk factors for
falling; or (3) BUA between 60 and 70
dB/MHzandat least 3 risk factors for fall-
ing. Furthermore, persons who were
completely immobileorpersonswhohad
sustainedahip fractureorhadahippros-
thesis on both sideswere excluded from
the study.Weconducted a substudy that
validated that persons who were in-
cluded in the study sustainedmore falls
and fractures than the persons not in-
cluded in the study because of being at
low risk for fractures (data not shown).
Each individual at high risk for hip
fracture was randomized to the inter-
vention or control group. Randomiza-
tion was performed in blocks of 4 after
stratification for sex and for age in
women (80 years vs80 years). Our
statistical departmentgenerated random-
ization lists by computer.All persons liv-
ing in the samehomewere first screened
by the research assistants, and subse-
quently randomized by one of the au-
thors (N.M.S.), in the same sequence in
which theyhadbeen screened.Random-
ization lists were not available to the re-
search assistants.
Both groups received written infor-
mation on bone health (eg, diet, sun-
shine exposure) and external risk fac-
tors for falls (eg, loose carpets). In the
intervention group, all participants re-
ceivedat least4hipprotectorsor5 incase
of urinary incontinence. In the control
group, participants did not receive a hip
protector. Participants and nurses were
taught about the increased risk for hip
fracture among institutionalized el-
derly, and about the causes and conse-
quences of hip fractures. In addition, in-
formation and instructions about theuse
of hip protectors were given. These in-
structions included information about
themechanismof the protector, the im-
portance of wearing the hip protector at
night, and laundering.Newsletterswere
sent to nurses to emphasize the impor-
tance of compliance. Participants were
not blinded to group assignment be-
cause it is difficult to design a shampro-
tector that does not have a small protec-
tive effect. In the intervention group, a
hip protector (Safehip) of the energy-
shunting type was used (Tytex, Ikast,
Denmark). Thehip protector consists of
2 shell-shaped protectors,made of poly-
propylene, which are sewn into special
underpants and cover the greater tro-
chanter.Hip protectorswere replaced in
case of loss or damage.
The primary outcome measurement
was time to first hip fracture. Falls and
fractureswere assessed prospectively by
using a participant-kept calendar. Hip
fractures and pelvic fractures were veri-
fied by the general practitioner. Partici-
pants were instructed to complete the
calendar on a weekly basis and to mail
the pages to the institute at the end of
every 3months for at least 1 year.When
a participantwas unable to complete the
calendar, a nurse acted as a proxy.When
the calendar was not fully completed,
completed incorrectly, or not returned
to the institute at theendof the3months,
the participant or nurse was contacted
by 1 of the authors or research assis-
tants.
Compliancewithwearing hip protec-
tors was assessed by unannounced vis-
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its by one of the research assistants at 1,
6, and 12 months after inclusion in the
study. At this visit, the participant was
checked to see if he/shewaswearing the
hip protector andwas interviewed about
hipprotectoruse.28 Inaddition, at theend
of eachperiodof the fall and fracture cal-
endar (1 period is 3 months), partici-
pants were asked whether they were
wearing thehipprotectorswhen they fell.
According to our power calculation,
700 elderly persons had to be followed
up for 1 year to detect a clinically im-
portant reduction in the incidence of hip
fractures from 4% in the control group
to 1% in the intervention group (1-
sided =.05, =.20). However, we en-
rolled only 561 participants, so the
power todetect a clinically important re-
duction (from 4% to 1%) in the inci-
dence of hip fractures was 74%. To in-
crease the number of events and
therefore the power, the follow-up du-
rationwas extended (mean, 69.6weeks).
This resulted in an incidence of hip frac-
tures of 7% in the control group. The
power to detect a reduction (from 7%
to 2%) in the incidence of hip fractures
was 89% (risk reduction of about 75%).
To examine the effect of external hip
protectors on the incidence of hip frac-
tures, the intention-to-treatprinciplewas
followed. The unadjusted relationship
between the intervention (useofhippro-
tectors) and time to first hip fracture and
time to death was examined using
Kaplan-Meier survival analysis. Sec-
ond, the risk ratio for recurrent falling
was calculated using the Cox propor-
tional hazards model with equal sur-
vival time for all participants. The risk
ratio was calculated instead of the odds
ratio because the incidence of recurrent
falling was higher than 10% and there-
fore, the odds ratio would have overes-
timated the effect. Individuals who fell
recurrently were defined as partici-
pants who fell at least twice within 6
months.29 Third, type of institution, cog-
nitive impairment, age, sex, and stra-
tum (1=men; 2=women aged 80
years; 3=women aged80 years) were
examined to determine if theymodified
the relationship between the use of hip
protectors and time to first hip fracture
using the Cox proportional hazards
model. When an interaction was statis-
tically significant (P.10), an interac-
tion term was added to the model.
Fourth, potential confounders were
added to the model: type of institution,
cognitive impairment, age, sex (if no in-
teraction was present), BUA, risk fac-
tors for falling, and recurrent falling.
Fifth, a per protocol analysis was per-
formed. In this analysis, participants from
the intervention groupwere included in
the analysis if theywere compliant at all
unannounced visits (n=78). In addi-
tion, participants and nurses from the
control groupwere asked to reportwhen
a participant from the control group
startedwearinghipprotectors.Theseper-
sons were excluded from the per proto-
col analyses (4 persons excluded; 281
included). Finally, the fracture rate per
fall was calculated for both the interven-
tionandcontrol groups.The fracture rate
per fallwas also calculated for thosewho
fell in the intervention group who were
reported to not have been wearing hip
protectors during any of the periods on
the fall and fracture calendar vs those
who fellwhowere reported tohave been
wearing hip protectors during 1 ormore
periods. All analyseswere performedus-
ing SPSS statistical software (version
9.0.1, SPSS Inc, Chicago, Ill).
RESULTS
In total, 830 elderly persons from 45
homes or apartment houses for the el-
derly and nursing homeswere screened
for risk for hip fracture between March
1999 and March 2001 and followed up
for hip fracture through March 2002
(FIGURE 1). Of these, 561 persons had a
high risk for hip fracture and were as-
signed to the intervention (n=276) or
control (n=285)groupby individual ran-
domization. The hip protectors were
marked prior to distribution with the
name and room number of the partici-
pant (median time between randomiza-
tion and startwas 2weeks). Both groups
startedwith the follow-upwhen the hip
protectors were distributed. Eight per-
sons in the interventiongroupand4per-
sons in the control groupdiedbeforedis-
tribution of the hip protectors in the
intervention group. In addition, oneper-
son from the intervention groupwasnot
able to start wearing hip protectors be-
cause of a hip fracture on the day before
randomization and then died. All per-
Figure 1. Amsterdam Hip Protector Study
276 Allocated to Intervention Group
268 Received Hip Protectors
8 Did Not Receive Hip Protectors
7 Died Before Start of Follow-up∗
1 Had Hip Fracture Before Start of Follow-up and Died
285 Allocated to Control Group
4 Died Before Start of Follow-up∗
269 Did Not Meet Inclusion Criteria
830 Persons Examined for Eligibility
561 Randomized
276 Persons Included in Analyses 285 Persons Included in Analyses
90 Lost to Follow-up
117 Discontinued Intervention
7 Persons Discontinued the Calendar
83 Persons Died
45 Within 1 mo
90 Within 6 mo
117 Within 12 mo
88 Lost to Follow-up
9 Persons 
Discontinued the Calendar
79 Persons Died
Calendar refers to the patient- or proxy-kept fall and fracture record. Asterisk indicates both groups started
with the follow-up when the hip protectors were distributed.
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sonswhowere randomized to the inter-
vention or control groupwere included
in the survival analyses. Total fol-
low-up timewas357person-years for the
intervention group and 398 person-
years for the control group. The base-
line characteristics of both groups are
presented in TABLE 1.
Therewasno significantdifferencebe-
tween the intervention and control
groups with regard to time to first hip
fracture in univariate analysis (log rank
P=.86; FIGURE 2). In the intervention
group, 18 hip fractures occurred in 18
persons (fracture rate of 5/100 person-
years); and in the control group, 20 hip
fractures occurred in 19 persons (frac-
ture rate of 5/100 person-years). In both
groups, one of the hip fractures oc-
curred between randomization and
distribution of the hip protector. When
excluding these hip fractures, the log-
rank P value was .85.
Eighty-three persons died in the in-
tervention group and 79 persons died in
the control group. Survival time until
deathwas similar in the intervention and
control groups (P=.31). Furthermore,
there were 100 individuals who experi-
enced recurrent falls in the interven-
tion group compared with 119 in the
control group (risk ratio, 0.87; 95%con-
fidence interval [CI], 0.67-1.13). Also,
the incidenceof other fractureswas com-
parable betweengroups. In the interven-
tion group, 16 other fractures occurred
(including 2pelvic fractures), and in the
control group, 14 other fractures oc-
curred (including 3 pelvic fractures).
In multiple analyses, no effect modi-
ficationwas found. After adjustment for
confounding, no significant difference
between participants from the interven-
tion and control groupswas foundwith
regard to time to first hip fracture (haz-
ard ratio, 1.05; 95% CI, 0.55-2.03). To
test the assumption of proportionality,
an interaction term of treatment70
weeks was added to the model. A cut-
off value of 70weekswas chosen to test
whether the effect of hip protectors on
hip fractures was significantly different
before and after 70 weeks (in Figure 2,
the effect appears to be slightly differ-
ent before and after 70 weeks). This in-
teraction term was not statistically sig-
nificant (P=.68), which indicates that
the effect of hip protectors on hip frac-
tures was not significantly different be-
fore and after 70 weeks.
Compliance with hip protectors at
unannounced visits was 132 (61%) of
217 individuals after 1 month (42 in-
dividuals were visited too late and not
included), 110 (45%) of 246 after 6
months, and 85 (37%) of 230 after 12
months.28 Individuals who died be-
fore the compliance visit were not in-
cluded in the compliance calculation.
During the interview, fewer than 16%
of the participants were found to be us-
ing the hip protectors at night.
While the overall compliance was
moderate to good in this study, 4 of 18
persons from the intervention group
werewearing hip protectors while frac-
turing their hip (13 persons were not
wearing hip protectors and in one hip
fracture, it was not clear). In 9 of 13 hip
fractures that occurred without a hip
protector in the intervention group, the
circumstances are known. One per-
son fell immediately after randomiza-
tion before the hip protectors were dis-
tributed; 4 persons fell late in the
evening or early in themorning; 1 per-
son was not wearing hip protectors be-
cause the hip protectors were being
washed; 1 person stopped wearing hip
protectors while bedridden and fell out
of bed afterward; and 2 persons fell dur-
ing the day (1 had stoppedwearing hip
protectors because of aesthetic reasons).
In the per protocol analysis, 78 com-
pliant participants from the interven-
tion groupwere comparedwith 281par-
ticipants from the control group. In the
intervention group, 4 hip fractures oc-
curred in 102person-years (fracture rate
of 3.9/100 person-years). In the control
group, 20 hip fractures occurred in 19
persons in394person-years (fracture rate
of 5.1/100 person-years). After adjust-
ment for confounding, persons from the
Figure 2. Cumulative Time Until First Hip
Fracture
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This analysis was performed to include all partici-
pants (including the persons who died) for the time
they participated.
Table 1. Baseline Characteristics of the Intervention and Control Groups
Characteristic
No. (%) of Individuals*
Intervention Group
(n = 276)
Control Group
(n = 285)
Age, mean (SD), y 84.8 (6.2) 85.7 (6.0)
Women 242 (87.7) 259 (90.9)
Live in nursing home 144 (52.2) 133 (46.7)
Hip fracture in the past 28 (10.1) 40 (14.0)
Broadband ultrasound attenuation,
mean (SD), dB/MHz
45.9 (12.5) 45.2 (12.1)
1 Falls in the last 6 mo 143 (51.8) 139 (48.8)
Dizziness† 52 (44.8) 71 (51.4)
Stroke with lasting consequences 28 (10.1) 27 (9.5)
Low physical activity 181 (65.6) 181 (63.5)
Urinary incontinence 198 (71.7) 200 (70.2)
Impaired mobility 198 (71.7) 193 (67.7)
Cognitive impairment 215 (77.9) 215 (75.4)
*Values expressed as number (percentage) unless otherwise indicated.
†Assessed in persons without cognitive impairment (116 in intervention group and 138 in control group).
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intervention group had a 23% lower
probability of fracturing a hip than per-
sons from the control group (FIGURE 3).
However, this difference was not statis-
tically significant (hazard ratio, 0.77;95%
CI, 0.25-2.38).
Finally, the fracture rate per fall was
calculated. In the intervention group
there were 18 hip fractures in 727 falls
(fracture rate per fall of 2.5%) and in the
control group there were 20 hip frac-
tures in 1075 falls (fracture rate per fall
of 1.9%). In TABLE 2, the hip fracture
rates per fall are presented according to
the number of periods that partici-
pants from the intervention group (or
their nurses) reported to be compliant
on the fall and fracture calendar.
COMMENT
Hipprotectorswere not effective in pre-
ventinghipfractures inthisstudyaccord-
ing to the intention-to-treat analysis. To
examine whether this was due to low
compliance, a per protocol analysis was
performed including only those partici-
pantswho actuallywore hip protectors.
In this analysis, a 23% nonsignificant
reduction in the incidence of hip frac-
tures was observed in the intervention
groupcomparedwith thecontrol group.
In addition, a lower fracture rate per fall
was found for thosewho fell, in the inter-
vention group, and reported compli-
ance for more calendar periods. How-
ever, the latter 2 analyses should be
interpretedwith caution because of low
statistical power. Finally, there were 4
persons in this studywho fracturedahip
while wearing the hip protector, indi-
catingthat the impactefficacyof thestud-
iedhipprotectorwas less thanexpected.
Todate, results of 11 randomizedcon-
trolled trials have been published, of
which4 studies (including our own)did
not observe a statistically significant re-
duction in the incidence of hip frac-
tures.18,20,21 The Cochrane review by
Parker et al12 concludes that hip protec-
tors appear to reduce the risk for hip
fracture within a selected population at
high risk for sustaining a hip fracture.
However, the4negative studieswerenot
included in this review. When consid-
ering the type of hip protector, the Safe-
hip hip protectorwas used in 6 random-
ized controlled trials. In 3 studies, the
Safehip hip protector reduced the inci-
dence of hip fractures (1 at borderline
statistical significance)13,19,22; and in 3
studies it did not (including ours).18,20
Our study was performed among in-
stitutionalizedelderlypersonsathighrisk
for hip fracture. We believe that the re-
sults of this trial can be generalized to
most institutionalized elderly persons,
because two thirds of the screenedpopu-
lation (561/830 persons) were at high
risk for hip fracture. According to our
screening criteria,more than half of our
patients were cognitively impaired (the
nursinghomepatients includedwere al-
most all cognitively impairedpatients be-
cause most patients with chronic medi-
cal conditions only were excluded due
to immobility).Cognitively impairedpa-
tients are an important group to study
because they are at high risk for hip frac-
ture. It is unclear how the compliance
will be in psychogeriatric patients.19,30 In
the first study, itwas reported thatwhen
demented patients acquire the habit of
wearing the hip protector, they usually
continue towear it. In the second study,
itwas reported thatdementia reduces the
compliance.
Themain strength of our study is that
itwas a large randomized controlled trial
(N=561) that used individual random-
ization to assign persons to an interven-
tion (hip protector) or control group. In
2 other studies that were both relatively
large (N=384 and N=548, respec-
tively) and used individual randomiza-
tion, hip protectors were also not effec-
tive in preventing hip fractures.20,21
However, in the second study, half of the
populationwas selectedat randomby the
head of nursing, which may have re-
sulted in selection bias. In addition, in
both studies fewer than 10 hip frac-
tures occurred, indicating that the sta-
tistical power may have been insuffi-
cient. Another important feature of our
study is that it resembles daily practice.
The study was performed in 45 differ-
ent homes for the elderly and nursing
homes in which nurses had to super-
vise the wearing of the hip protectors.
Some of the other studies conclud-
ing that hip protectors were not effec-
tive in preventing hip fractures indicate
Figure 3. Cumulative Time Until First Hip
Fracture (per Protocol Analysis)
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Cox proportional hazards model was used. The maxi-
mum survival time was 97 weeks because the model
presents the cumulative hazard curves until the last
hip fracture.
Table 2. Hip Fracture Rate per Fall in Intervention Group*
Group
No. of
Individuals
No. of
Falls
No. of Hip
Fractures†
Hip Fracture
Rate per Fall, %‡
Intervention hip protector
compliance period
0 59 208 9 4.3
1 104 513 7 1.4
2 51 364 4 1.1
3 30 257 1 0.4
4 14 161 1 0.6
Control 285 1075 20 1.9
*According to the number of periods (1 period is 3 months on the fall and fracture calendar; this question was only
asked when a participant had fallen during this period) that participants were compliant in wearing hip protectors.
†Two hip fractures are missing (1 hip fracture occurred before hip protectors were distributed and the second hip frac-
ture was in a participant who died shortly after the first period and information was missing).
‡Calculated as (number of hip fractures/number of falls) multiplied by 100.
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that this may be due to a lack of power.
The realized power of our study to de-
tect a clinically important reduction from
4% to 1% in the incidence of hip frac-
tures was 74%. We chose an expected
risk reduction of 75%because in 2 large
studies that were performed before we
started our trial, risk reductions of 56%
to 67% were found with a compliance
lower than 50%.13,15 However, now that
more studies are published, this risk re-
duction probably was overestimated.
The compliance in our study was
moderate togoodandsimilar to the com-
pliance in most other studies.13,15-18,21,28
Compliance was aided by newsletters,
whichemphasizedpoints suchas the im-
portance of wearing hip protectors at
night. In addition, theunannounced vis-
its may have had a small positive effect
becausenoncompliant participantswere
encouraged towear hip protectors at the
end of the visit. The compliance at the
unannounced visits changed from 61%
to 37% during follow-up. At the mo-
ment of hip fracture, 22% of the partici-
pantswerewearing ahipprotector (4/18
participants). An important reason for
this discrepancy in compliance is that
fewer than 16%of the participants were
wearinghipprotectors atnight, and4hip
fractures in the intervention group oc-
curred late in the evening or early in the
morning. In the study by Jantti et al,31
which was performed in nursing home
residents, 59 of 207 falls occurred dur-
ing thenight.Compliance at nightmight
increase if thehipprotector ismademore
comfortable. Another possibility is to
combine thehip protectorwith other in-
terventions, such as a movement sen-
sor, which alerts the nursewhen the pa-
tient is getting out of bed; a softer hip
protector during the night; or fall pre-
vention strategies.32
Another problemwe encountered is
that the number of hip protectors pro-
videdwas not always sufficient. In some
homes, it was not possible to wash the
hip protectors during theweekends and
sometimes this resulted in a shortage,
especially in persons who were incon-
tinent of urine. In our study, 1 person
fractured a hip while all hip protec-
tors were being washed. It is possible
that persons who were noncompliant
at night or due to a shortage of hip pro-
tectors were compliant during the un-
announced visits and were included in
the per protocol analysis. Thismayhave
diluted the effects of this analysis.
In future research, it would be in-
teresting to examine whether the use
of hip protectors influences the activ-
ity level of the participant. None of the
studies to date used a sham hip pro-
tector. Because the participants and
their nurses were notmasked to the in-
tervention, it is possible that the pres-
ence of the hip protector changed the
person’s activity level, and subse-
quently the risk for falls and fractures.
In conclusion, the studiedhipprotec-
tor was not effective in preventing hip
fractures in this study.Possiblecauses for
this lack of effectiveness include com-
pliance, which was moderate to good
during the day, but low at night; and
lower impacteffectiveness thanexpected.
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